A detailed history of Inverness Counsel LLC transactions in Pfizer Inc stock. As of the latest transaction made, Inverness Counsel LLC holds 19,406 shares of PFE stock, worth $515,423. This represents 0.05% of its overall portfolio holdings.

Number of Shares
19,406
Previous 18,606 4.3%
Holding current value
$515,423
Previous $976,000 13.01%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $35,008 - $42,736
800 Added 4.3%
19,406 $849,000
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $23,358 - $27,695
502 Added 2.77%
18,606 $976,000
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $91,362 - $113,209
-1,997 Reduced 9.93%
18,104 $937,000
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $86,317 - $127,951
-2,089 Reduced 9.41%
20,101 $1.19 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $27,475 - $35,294
-700 Reduced 3.06%
22,190 $954,000
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $76,847 - $87,055
-2,140 Reduced 8.55%
22,890 $896,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $68,654 - $77,428
-2,050 Reduced 7.57%
25,030 $907,000
Q4 2020

Jan 27, 2021

SELL
$33.47 - $42.56 $52,849 - $67,202
-1,579 Reduced 5.51%
27,080 $997,000
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $54,667 - $66,320
-1,815 Reduced 5.96%
28,659 $937,000
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $27,084 - $38,697
-1,002 Reduced 3.18%
30,474 $995,000
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $1,646 - $1,868
-50 Reduced 0.16%
31,476 $1.23 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $76,286 - $98,921
-2,348 Reduced 6.93%
31,526 $1.13 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $143,778 - $161,429
-3,888 Reduced 10.3%
33,874 $1.47 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $162,187 - $178,190
-4,325 Reduced 10.28%
37,762 $1.6 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $22,812 - $26,008
-593 Reduced 1.39%
42,087 $1.74 Million
Q3 2018

Oct 30, 2018

BUY
$34.47 - $41.81 $25,990 - $31,524
754 Added 1.8%
42,680 $1.88 Million
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $93,630 - $99,819
-2,839 Reduced 6.34%
41,926 $1.52 Million
Q1 2018

May 02, 2018

BUY
$31.91 - $37.02 $141,425 - $164,072
4,432 Added 10.99%
44,765 $1.59 Million
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $313,641 - $332,784
-9,430 Reduced 18.95%
40,333 $1.46 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $1.54 Million - $1.7 Million
49,763
49,763 $1.78 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.